中国经济网北京10月22日讯 星宸科技(301536.SZ)近日披露的公告显示，公司已于2025年9月26日向 香港联交所递交发行境外上市股份（H股）并在香港联交所主板挂牌上市的申请，并于同日在香港联交 所网站上刊登本次发行并上市的申请资料。 星宸科技本次港股上市的联席保荐人是中金公司、中信建投国际。 星宸科技于2025年9月29日披露的关于公司股东减持计划实施情况暨减持完毕的公告显示，近日， 收到公司股东昆桥资本及其一致行动人昆宸出具的《关于股份减持计划实施完毕的告知函》，截止2025 年9月28日，在减持计划实施期间，昆桥资本与一致行动人昆宸通过大宗交易和集合竞价方式累计减持 公司股份9,616,632股，持有公司股份比例下降至3.8364%，减持情况与此前已披露的减持计划一致，减 持数量在减持计划范围内。 按星宸科技披露的减持价格区间，昆桥资本及其一致行动人昆宸2025年7月1日至2025年9月28日共 计套现区间在5.63亿元至6.61亿元。 | 股东名称 | 减持方式 | 减持期间 | 减持价格区间 (元/股) | 减持股数 (股) | 减持股数占目 前总股本比例 | | --- | --- | - ...

格隆汇10月21日｜中国证监会国际合作司发布关于苏州纳芯微电子股份有限公司境外发行上市备案通知 书，公司拟发行不超过40,976,900股境外上市普通股并在香港联合交易所上市。 ...

纳芯微：发行境外上市外资股（H股）获得中国证监会备案。 ...

中国经济网北京10月21日讯 帝奥微(688381.SH)今日复牌，开盘报31.36元，上涨11.56%。 帝奥微昨晚披露的发行股份及支付现金购买资产并募集配套资金预案显示，上市公司拟通过发行股 份及支付现金购买董志伟等16名交易对方持有的荣湃半导体100%股权。本次交易完成后，荣湃半导体 成为上市公司的全资子公司。 | 房貸 | 名称 | 认缴出资金 額(万元) | 比例 | | --- | --- | --- | --- | | 15 | 东方茸世(烟台)创业投资合伙企业(有限合伙) | 8.03 | 0.50% | | IR | 北京君利联合创业投资合伙企业(有限合伙) | 1.62 | 0.10% | | | 合计 | 1,605.63 | 100.00% | 标的资产的最终交易价格将以符合《证券法》规定的资产评估机构出具的评估报告的评估结果为基 础，经交易双方充分协商确定。标的资产相关审计、评估工作完成后，上市公司将与交易对方签署最终 交易协议，对最终交易价格和股份支付比例和支付数量等交易方案详细内容进行确认，并在重组报告书 中予以披露。 上市公司本次交易现金对价的资金来源包括：募集配套资金、自有资 ...

创金合信芯片产业股票发起A（013339）成立日期2021年9月28日，最新规模2.91亿。今年以来收益 29.71%，同类排名1461/4218；近一年收益39.88%，同类排名785/3868；成立以来收益27.56%。 创金合信芯片产业股票发起A（013339）基金经理为刘扬。 截至发稿，刘扬累计任职时间4年12天，现任基金资产总规模10.25亿元，任职期间最佳基金回报 76.96%， 任职期间最差基金回报-3.2%。 10月21日，灿芯股份涨5.01%，截至发稿，报136.50元/股，成交6.37亿元，换手率6.73%，总市值163.80 亿元。 资料显示，灿芯半导体(上海)股份有限公司位于中国(上海)自由贸易试验区张东路1158号礼德国际2号楼 7楼，成立日期2008年7月17日，上市日期2024年4月11日，公司主营业务涉及提供一站式芯片定制服务 的集成电路设计服务。主营业务收入构成为：芯片设计业务50.27%，芯片量产业务49.73%。 从基金十大重仓股角度 数据显示，创金合信基金旗下1只基金重仓灿芯股份。创金合信芯片产业股票发起A（013339）二季度 增持22.37万股，持有股数52.31万 ...

人民财讯10月20日电，美芯晟(688458)10月20日披露2025年三季度报告，公司第三季度实现营业收入 1.56亿元，同比增长66.31%；归母净利润531.29万元，同比增长132.74%。前三季度实现营业收入4.22亿 元，同比增长46.47%；归母净利润1031.98万元，同比增长132%。 ...

Core Viewpoint - Yunnan Xiyao Technology Co., Ltd. has been established with a registered capital of 1 million RMB, focusing on various technology and manufacturing services in the semiconductor and electronic sectors [1] Company Overview - The legal representative of Yunnan Xiyao Technology Co., Ltd. is Zhao Jian [1] - The company has a registered capital of 1 million RMB [1] Business Scope - The company’s business activities include software development, professional design services, industrial engineering design services, integrated circuit design, and manufacturing of optoelectronic devices [1] - It also engages in the sales of integrated circuit chips and products, as well as the repair, manufacturing, and sales of instruments and meters [1] - Additional services include technology services, development, consulting, and various forms of trade including import and export [1] - The company is involved in human resources services, enterprise management, and training services, excluding those requiring special licenses [1]

Core Insights - The A-share IPO review maintained a "full approval" pace from October 13 to 17, with three companies successfully passing the review, highlighting a focus on hard technology enterprises [2][3][4] Recent Approvals - **Tiansu Measurement**: On October 16, Tiansu Measurement's IPO application was approved after four previous suspensions. The company projects steady revenue growth from CNY 597 million in 2023 to CNY 800 million in 2025, with net profits increasing from CNY 84.39 million to CNY 111 million during the same period [2] - **Angrui Microelectronics**: Approved on October 15, Angrui Microelectronics aims to raise CNY 2.067 billion for the development of 5G RF front-end chips and related projects. The company specializes in RF and analog integrated circuit design [3] - **Yuxun Technology**: Yuxun Technology's IPO was approved after a previous deferral. The company focuses on optical communication chips and plans to raise CNY 809 million for various development projects, with projected revenues growing from CNY 313 million in 2023 to CNY 411 million in 2024 [4] New Listings - **Changjiang Energy Technology**: Listed on the Beijing Stock Exchange on October 16, with a share price increase of 254.03%. The company raised CNY 160 million for expanding production capacity and R&D in energy equipment [5] - **Yunji Technology**: Listed on the Hong Kong Stock Exchange on October 16, with a first-day price increase of 26.05%. The company raised approximately HKD 660 million, with significant oversubscription [6] - **Xuanzhu Biopharmaceutical**: Listed on October 15, with a first-day increase of 126.72%. The company focuses on innovative drug development in the biopharmaceutical sector [7] Recent Filings - **Shouchuang Securities**: Filed for a dual listing on the Hong Kong Stock Exchange, reporting total revenues of approximately CNY 2.519 billion in 2022, with a projected growth trend [8] - **Shuanglin Co.**: Recently submitted a prospectus for listing on the Hong Kong Stock Exchange, reporting a revenue of CNY 2.525 billion in the first half of 2025, with a 20.1% year-on-year growth [9] - **Tambor Group**: Filed for a listing on the Hong Kong Stock Exchange, focusing on outdoor apparel with a revenue of approximately CNY 732 million in 2022 [10] - **Chengyi Biotech**: Submitted a prospectus for a Hong Kong listing, focusing on developing new oral small molecule drugs for cardiovascular and metabolic diseases [11] - **Dongpeng Beverage**: Filed for a listing on the Hong Kong Stock Exchange, reporting a revenue of CNY 8.5 billion in 2022, with a leading market position in the functional beverage sector [12]

Core Viewpoint - The company, Cambrian (688256), reported significant growth in its financial performance for the third quarter and the first three quarters of the year, driven by the expanding market for artificial intelligence applications and a strategic focus on AI chip development [1][2]. Financial Performance - For the first three quarters, Cambrian achieved a revenue of 4.607 billion yuan, representing a year-on-year increase of 2386.38%, and a net profit of 1.605 billion yuan, compared to a loss of 724.5 million yuan in the same period last year, with basic earnings per share of 3.85 yuan [1]. - In the third quarter alone, Cambrian reported a revenue of 1.727 billion yuan, up 1332.52% year-on-year, and a net profit of 567 million yuan [1]. - In the first half of 2025, Cambrian's revenue reached 2.881 billion yuan, a staggering year-on-year growth of 4347.82%, with a net profit of 1.038 billion yuan and a non-recurring net profit of 913 million yuan, marking a successful turnaround [2]. Research and Development - Cambrian maintained a high level of R&D investment in the first three quarters, which increased compared to the previous year. However, the proportion of R&D expenditure relative to revenue decreased due to the substantial growth in revenue [1]. Market Position and Strategy - Cambrian has focused on the research and development of AI chips since its inception, aiming to create core processor chips for the AI sector. Its main business includes the R&D, design, and sales of AI core chips for various applications, including cloud servers and edge computing devices [1]. - The company is leveraging its core advantages in AI chip products to deepen technical collaborations with leading enterprises in cutting-edge fields, thereby expanding its market scale [2]. - Cambrian plans to capitalize on the strategic opportunities presented by the increasing integration of AI technology across various industries, enhancing its market expansion efforts [2]. Strategic Partnerships - Cambrian recently announced a strategic partnership with SenseTime, focusing on joint optimization of software and hardware, which has positively impacted stock prices for both companies [3].

Core Viewpoint - Beijing Angrui Microelectronics Technology Co., Ltd. has received approval for its IPO application on the Sci-Tech Innovation Board, focusing on RF and analog integrated circuit design, with significant contributions to China's RF field and product development [1][2]. Group 1: Company Overview - Angrui Micro was established in 2012 and specializes in the research, design, and sales of RF front-end chips, RF SoC chips, and other analog chips [1]. - The company has led or participated in six national and multiple local major scientific research projects, contributing to foundational research and industrial application in the RF field [1]. Group 2: IPO Details - The company plans to publicly issue no more than 24.8829 million shares, raising approximately 2.067 billion RMB [2]. - The raised funds will be allocated as follows: 1.096 billion RMB for 5G RF front-end chip and module R&D and industrial upgrades, 408 million RMB for RF SoC R&D and upgrades, and 563 million RMB for headquarters and R&D center construction [2]. Group 3: Financial Performance - Angrui Micro has been operating at a loss since 2022, with total revenues of 923 million RMB in 2022, projected to reach 2.101 billion RMB in 2024, and 844 million RMB in the first half of 2025 [2]. - The net profits for the same periods are -290 million RMB, -450 million RMB, -64.7092 million RMB, and -40.2995 million RMB, respectively, with cumulative unremedied losses of 1.279 billion RMB by mid-2025 [2]. Group 4: Customer Concentration and Shareholding Structure - The company has a high customer concentration, with the top five customers accounting for 70.44%, 75.84%, 69.52%, and 59.07% of total revenue during the reporting periods [3]. - Major customer A's purchasing amounts were 43.8984 million RMB, 626 million RMB, 707 million RMB, and 169 million RMB, with a year-on-year decline in the first half of 2025 [3]. - The shareholding structure shows that Beijing Xinke holds 9.12%, Nanjing Tongxin 7.28%, Nanjing Chuangxin 7.01%, and Nanjing Ruida 5.97%, with the chairman controlling 21.95% of voting rights directly and 38.91% indirectly [3].